Breast Neoplasms: all 12,828 studies
Page 60 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.
- Clinical Validation of an Artificial Intelligence Algorithm to Help Interpret MammogramsCompletedNCT05640011
- Time-restricted Eating in Survivors TrialCompletedNCT05639829Not applicable
- Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer PatientsActive, not recruitingNCT05637216Phase 2
- Couples' QOL in Metastatic Breast CancerActive, not recruitingNCT05636943Not applicable
- Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/LetrozoleCompletedNCT05635357
- Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast CancerWithdrawnNCT05634954Phase 1
- Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of TreatmentCompletedNCT05634395Not applicable
- Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast CancerActive, not recruitingNCT05633979Phase 1
- Circulating Tumor Cells Screen for Breast CancerStatus unknownNCT05633680
- Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort StudyActive, not recruitingNCT05632601Not applicable
- A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast CancerCompletedNCT05629949Phase 3
- A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)Active, not recruitingNCT05629585Phase 3
- Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)Active, not recruitingNCT05629065Not applicable
- Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase InhibitorsStatus unknownNCT05628077
- Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or RibociclibTerminatedNCT05625087Phase 2
- CAR T Cells in Mesothelin-Expressing Breast CancerTerminatedNCT05623488Phase 1
- A Deep Learning Method to Evaluate QT on RibociclibCompletedNCT05623397
- Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.Status unknownNCT05623280
- 99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast CancerStatus unknownNCT05622240Early Phase 1
- 68Ga PET/CT Imaging in Breast Cancer PatientsStatus unknownNCT05622227Phase 1/2
- A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast CancerTerminatedNCT05622058Phase 1
- Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerActive, not recruitingNCT05620134Phase 1/2
- Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer SurvivorsCompletedNCT05615753Phase 1
- Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast CancerCompletedNCT05615298
- Characterizing Breast Cancer With 18F-FES PET/CTStatus unknownNCT05613270Not applicable
- Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer PatientsActive, not recruitingNCT05612100
- The 24 Hour Effects of Remedial Exercises With and Without Compression Therapy on Breast Cancer-related LymphedemaCompletedNCT05610579Not applicable
- Atezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast CancerCompletedNCT05609903
- Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast CancerCompletedNCT05609435Not applicable
- The Influence of Treatment Position (Prone vs. Supine) on Whole Breast TargetStatus unknownNCT05609058Not applicable
- Breast Cancer Screening Uptake: a Randomized Controlled Trial Assessing the Effect of a Decisional AidCompletedNCT05607849Not applicable
- Losartan in Prevention of Radiation-Induced Heart FailureCompletedNCT05607017Early Phase 1
- (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerActive, not recruitingNCT05607004Phase 2
- Factor Influencing Breast Surgery Type Decision-MakingCompletedNCT05604677
- Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)Status unknownNCT05603013Phase 2
- A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast CancerWithdrawnNCT05600582Phase 1
- The Effect of Digital Breast Tomosynthesis in Breast Cancer Long-term Survival: a Single Institution StudyCompletedNCT05600257
- Axillary Versus Primary Breast Approach for Second-stage Breast ReconstructionStatus unknownNCT05600153Not applicable
- ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer StudyActive, not recruitingNCT05596409Phase 2
- Improving Exercise Capacity With a Tailored Physical Activity InterventionActive, not recruitingNCT05595577Not applicable
- Effect of Lymphedema Prevention Program Based on Theory of Knowledge-attitude-practice on Postoperative Breast Cancer PatientsCompletedNCT05595330Not applicable
- Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer PatientsStatus unknownNCT05595109Phase 2/3
- A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer PatientsActive, not recruitingNCT05594498Not applicable
- Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast CancerStatus unknownNCT05594082
- An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast CancerTerminatedNCT05592483
- Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation RegimenActive, not recruitingNCT05591547Phase 2
- Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer PatientsCompletedNCT05591456Phase 3
- Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority TrialStatus unknownNCT05590559Not applicable
- Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom MonitoringActive, not recruitingNCT05587972Not applicable
- Epidemiology of TNBC in Asyut Clinical Oncology DepartmentStatus unknownNCT05586659
- Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer SurgeryCompletedNCT05583981
- Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast CancerTerminatedNCT05583110Phase 2
- Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene CopolymerplasmidCompletedNCT05578820Phase 1
- Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast CancerStatus unknownNCT05577442Phase 2
- SexoMBC2 Non Interventional StudyCompletedNCT05577156
- Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing TreatmentCompletedNCT05576545Not applicable
- Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02)Active, not recruitingNCT05574920Not applicable
- Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01)Active, not recruitingNCT05574907Not applicable
- Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast CancerActive, not recruitingNCT05574881Phase 1/2
- Evaluation of the Diagnostic Performance of a Bra Prototype to Detect Breast CancerCompletedNCT05574816Not applicable
- Metastatic Breast Cancer-Specific Prognostic ToolCompletedNCT05574478
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)TerminatedNCT05573555Phase 1/2
- Impact of a Patient Decision Aid InterventionCompletedNCT05573022Not applicable
- Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus TrastuzumabCompletedNCT05572645
- The Rechallenge of ADCs in MBC PatientsActive, not recruitingNCT05571618
- Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian SamplesCompletedNCT05570266
- NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE TrialActive, not recruitingNCT05569811Phase 2
- Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast CancerCompletedNCT05569187
- Doxil/Caelyx BE StudyCompletedNCT05567601Phase 1
- Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer PatientsStatus unknownNCT05566613
- HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BCStatus unknownNCT05566457Phase 2
- Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast CancerActive, not recruitingNCT05563220Phase 1/2
- GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.CompletedNCT05562518Phase 4
- The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian PopulationCompletedNCT05562440Not applicable
- SMART-ER: Symptom Monitoring With Patient-reported OutcomesTerminatedNCT05560685Not applicable
- BRaziLian outcomE for metAStatic breasT CancerStatus unknownNCT05559528
- Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast SurgeryStatus unknownNCT05558917Not applicable
- F-Tryptophan PET/CT in Human CancersCompletedNCT05556473Phase 1
- Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast CancerCompletedNCT05555706Phase 2/3
- Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast CancerActive, not recruitingNCT05552001Phase 3
- Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBCStatus unknownNCT05550090
- E-Health Support Program (PACK Health Program) in Supporting Patient Reported Symptoms in Newly Diagnosed Patients With Breast CancerCompletedNCT05549687Not applicable
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)Active, not recruitingNCT05548127Phase 1/2
- Study of Oral MRT-2359 in Selected Cancer PatientsActive, not recruitingNCT05546268Phase 1/2
- Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast CancerStatus unknownNCT05546255Phase 2
- Nociception Level Monitor (NOL) During Guided Analgesic Delivery in Breast SurgeriesCompletedNCT05546021Not applicable
- Health-promoting Lifestyle in a Genetic Counseling ClinicCompletedNCT05545254
- The Treatment Situation of Chinese County Population With Breast CancerStatus unknownNCT05544123
- Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast CancerWithdrawnNCT05539365Phase 2
- Portable Scalp Cooling System for the Improvement of Chemotherapy-Induced Hair Loss in Patients With Metastatic Breast CancerWithdrawnNCT05533320Not applicable
- Tele-rehabilitation in Women With Breast Cancer During COVID-19 Pandemic.Status unknownNCT05530876Not applicable
- Trans-RosaLEE Study: a Biomarker-directed, Translational StudyActive, not recruitingNCT05529862Not applicable
- Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)CompletedNCT05528263Not applicable
- A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer ScreeningCompletedNCT05526872Not applicable
- Effect of Physical Activity in Patients With Breast Cancer.WithdrawnNCT05523063
- Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMEDCompletedNCT05520723Phase 2
- Water and Land-based Aerobic Training in Breast Cancer SurvivorsActive, not recruitingNCT05520515Not applicable
- Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant TherapyCompletedNCT05519397
- Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast CancerCompletedNCT05519059Phase 1
- A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerActive, not recruitingNCT05514054Phase 3